Business / Finance

RSS

Morphotek acquires tumor targeting assets from TMI

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular, Inc. for an undisclosed upfront payment and future development milestones.

4 Apr 2011

CompCare fourth quarter total revenue increases 371% to $17.9 million

Comprehensive Care Corporation today reported results for the fourth quarter and year ended December 31, 2010.

4 Apr 2011

International Isotopes 2010 net loss increases 49% to $6,802,014

International Isotopes Inc. announces the financial results for fiscal year ended December 31, 2010.

4 Apr 2011

Sigma-Aldrich establishes European Regional Headquarters in Switzerland

Sigma-Aldrich Corporation opened its European Regional Headquarters today in St. Gallen, Switzerland. The new Einstein Facility located in the heart of St. Gallen will be home to approximately 50 employees.

4 Apr 2011

Southern Home Medical reports 6.6% increase in 2010 revenues

Southern Home Medical Equipment, Inc., a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, announced today that the unaudited results from operations for fiscal year 2010 reflects a 6.6% increase in revenues with profitability over previous 2009 year-end.

4 Apr 2011

Axxora.com to distribute TGR's new ELISAONE technology assay reagents in the US and South America

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Axxora.com of San Diego, CA, US, a leading online global market place resource for innovative and high quality Life Science research reagents.

4 Apr 2011

Pronto to distribute Signal's Myeloma Prognostic Risk Signature test in Israel

Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.

4 Apr 2011

Medela acquires Ontario-based Bravado Designs

This acquisition unifies Medela, a leading brand for breastfeeding solutions, with Bravado, an innovating leader in the nursing apparel category.

4 Apr 2011

Daiichi Sankyo acquires Plexxikon

Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million.

4 Apr 2011

NCI acquires AdvanceMed

NCI, Inc., a leading provider of information technology (IT), engineering, logistics, and professional services and solutions to U.S. Federal Government agencies, announced today that it has acquired the outstanding capital stock of AdvanceMed Corporation, an affiliate of CSC.

4 Apr 2011

Catalyst Health Solutions to sell 5,500,000 shares of common stock

Catalyst Health Solutions, Inc. today announced that it plans to sell 5,500,000 shares of its common stock, subject to market and other conditions, of which 4,500,000 shares will be sold by the Company and 1,000,000 shares will be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., in an underwritten public offering pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission.

4 Apr 2011

Vermillion, Quest Diagnostics enter agreement to launch OVA1 IVDMIA assay in India

Vermillion, a molecular diagnostics company, today announced that it has signed an agreement with Quest Diagnostics to make OVA1 available in India. The companies are targeting a launch in the second quarter of 2011. Additionally, at the International Gynecologic Cancer Society (IGCS) regional meeting held in New Delhi April 2-3, 2011, Dr. Fred Ueland presented data demonstrating the high sensitivity for ovarian malignancy of OVA1 in combination with ultrasound.

From Quest Diagnostics 4 Apr 2011

Quest Diagnostics completes Athena Diagnostics acquisition

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced it has completed its previously announced acquisition of Athena Diagnostics, an esoteric laboratory specializing in genetic testing for neurological disorders, from Thermo Fisher Scientific.

From Quest Diagnostics 4 Apr 2011

KKR affiliate to acquire Pfizer's Capsugel business

Pfizer and Kohlberg Kravis Roberts & Co L.P. (together with its affiliates, "KKR") today announced they have entered into an agreement whereby an affiliate of KKR will acquire Pfizer's Capsugel business for $2.375 billion in cash. Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems, generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules in 2010.

4 Apr 2011

Bruker closes acquisition of Michrom

Bruker today announced the closing of its acquisition of Michrom Bioresources, Inc. (Michrom), a 20 year old, privately owned company located in Auburn, California, after receiving unanimous Michrom shareholder approval. The acquisition is not expected to have a material effect on Bruker's 2011 financials.

4 Apr 2011

GeneLink net sales decrease 8.4% to $7,839,972 for 2010

GeneLink, Inc., a leading consumer genomics biotech company, today reported financial results for the fiscal year ended December 31, 2010.

4 Apr 2011

DJO Global intends to offer $300 million in senior notes due 2018

DJO Global, Inc. today announced that its indirect wholly owned subsidiaries, DJO Finance LLC and DJO Finance Corporation, a wholly owned subsidiary of DJOFL, intend to offer, in a private offering subject to market and other conditions, $300 million aggregate principal amount of senior unsecured notes due 2018.

4 Apr 2011

Esaote acquires 3mensio

Esaote International NV and 3mensio Medical Imaging BV have entered into an agreement pursuant to which Esaote acquires 3mensio in order to expand its leading role in healthcare information technology.

4 Apr 2011

OncoSec acquires certain assets of Inovio

OncoSec Medical Incorporated, a developer of innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today that on March 24, 2011 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc. and entered into a license agreement with Inovio, pursuant to the terms of an asset purchase agreement with Inovio entered into on March 14, 2011.

4 Apr 2011